The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
Guangjian Li, Xu Wang, Dihui Ma Department of Neurology and Neuroscience Center, First Hospital of Jilin University, Changchun, People’s Republic of China Background: Vortioxetine is an investigational multimodal antidepressant. We conducted this meta-analysis to assess the efficacy and...
Saved in:
Main Authors: | Li G, Wang X, Ma D |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/1db9583fa120422ab8c7f7e5b2bbf9fe |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
by: McIntyre RS, et al.
Published: (2021) -
The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
by: Fu J, et al.
Published: (2016) -
Cognitive impairment in depression: recent advances and novel treatments
by: Perini G, et al.
Published: (2019) -
Pioglitazone could induce remission in major depression: a meta-analysis
by: Colle R, et al.
Published: (2016) -
Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
by: Huang Q, et al.
Published: (2016)